The latest study on Chronic Obstructive Pulmonary Disease Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Chronic Obstructive Pulmonary Disease Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Chronic Obstructive Pulmonary Disease and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Chronic Obstructive Pulmonary Disease Market Analysis By Type Segment:
Bronchodilators
Glucocorticoids
Other
Chronic Obstructive Pulmonary Disease Market Analysis By Application Segment:
Prevention
Diagnostic
Treatment
Chronic Obstructive Pulmonary Disease Market Analysis By Regions (Countries):
The Chronic Obstructive Pulmonary Disease Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Chronic Obstructive Pulmonary Disease Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Chronic Obstructive Pulmonary Disease Market:
Chronic Obstructive Pulmonary Disease market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Chronic Obstructive Pulmonary Disease Market status and future forecast.
To present the key Chronic Obstructive Pulmonary Disease Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (2016-2027)
1.4.2 Bronchodilators
1.4.3 Glucocorticoids
1.4.4 Other
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
1.5.2 Prevention
1.5.3 Diagnostic
1.5.4 Treatment
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Chronic Obstructive Pulmonary Disease Market Size
2.2 Chronic Obstructive Pulmonary Disease Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease Market Size by Regions (2016-2027)
2.2.2 Chronic Obstructive Pulmonary Disease Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Chronic Obstructive Pulmonary Disease Market Size by Manufacturers
3.1.1 Global Chronic Obstructive Pulmonary Disease Revenue by Manufacturers (2020)
3.1.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Manufacturers (2020)
3.1.3 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Obstructive Pulmonary Disease Key Players Head office and Area Served
3.3 Key Players Chronic Obstructive Pulmonary Disease Product/Solution/Service
3.4 Date of Enter into Chronic Obstructive Pulmonary Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020)
4.2 Global Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020)
5 United States
5.1 United States Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
5.2 Chronic Obstructive Pulmonary Disease Key Players in United States
5.3 United States Chronic Obstructive Pulmonary Disease Market Size by Type
5.4 United States Chronic Obstructive Pulmonary Disease Market Size by Application
6 Europe
6.1 Europe Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
6.2 Chronic Obstructive Pulmonary Disease Key Players in Europe
6.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Type
6.4 Europe Chronic Obstructive Pulmonary Disease Market Size by Application
7 China
7.1 China Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
7.2 Chronic Obstructive Pulmonary Disease Key Players in China
7.3 China Chronic Obstructive Pulmonary Disease Market Size by Type
7.4 China Chronic Obstructive Pulmonary Disease Market Size by Application
8 Japan
8.1 Japan Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
8.2 Chronic Obstructive Pulmonary Disease Key Players in Japan
8.3 Japan Chronic Obstructive Pulmonary Disease Market Size by Type
8.4 Japan Chronic Obstructive Pulmonary Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
9.2 Chronic Obstructive Pulmonary Disease Key Players in Southeast Asia
9.3 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Type
9.4 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Application
10 India
10.1 India Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
10.2 Chronic Obstructive Pulmonary Disease Key Players in India
10.3 India Chronic Obstructive Pulmonary Disease Market Size by Type
10.4 India Chronic Obstructive Pulmonary Disease Market Size by Application
11 Central & South America
11.1 Central & South America Chronic Obstructive Pulmonary Disease Market Size (2016-2020)
11.2 Chronic Obstructive Pulmonary Disease Key Players in Central & South America
11.3 Central & South America Chronic Obstructive Pulmonary Disease Market Size by Type
11.4 Central & South America Chronic Obstructive Pulmonary Disease Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Obstructive Pulmonary Disease Introduction
12.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.1.5 AstraZeneca Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Obstructive Pulmonary Disease Introduction
12.2.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.2.5 GSK Recent Development
12.3 MSD
12.3.1 MSD Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Obstructive Pulmonary Disease Introduction
12.3.4 MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.3.5 MSD Recent Development
12.4 Sunovion
12.4.1 Sunovion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Obstructive Pulmonary Disease Introduction
12.4.4 Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.4.5 Sunovion Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Obstructive Pulmonary Disease Introduction
12.5.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.5.5 Novartis Recent Development
12.6 Roche Group
12.6.1 Roche Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Obstructive Pulmonary Disease Introduction
12.6.4 Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.6.5 Roche Group Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Obstructive Pulmonary Disease Introduction
12.7.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.7.5 Pfizer Recent Development
12.8 Jubilant Pharma Limited
12.8.1 Jubilant Pharma Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Obstructive Pulmonary Disease Introduction
12.8.4 Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.8.5 Jubilant Pharma Limited Recent Development
12.9 Almirall
12.9.1 Almirall Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Obstructive Pulmonary Disease Introduction
12.9.4 Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.9.5 Almirall Recent Development
12.10 Horizon Pharma
12.10.1 Horizon Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Chronic Obstructive Pulmonary Disease Introduction
12.10.4 Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2020)
12.10.5 Horizon Pharma Recent Development
12.11 Boehringer Ingelheim
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Chronic Obstructive Pulmonary Disease Key Market Segments
Table Key Players Chronic Obstructive Pulmonary Disease Covered
Table Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type 2016-2027
Figure Bronchodilators Figures
Table Key Players of Bronchodilators
Figure Glucocorticoids Figures
Table Key Players of Glucocorticoids
Figure Other Figures
Table Key Players of Other
Table Global Chronic Obstructive Pulmonary Disease Market Size Growth by Application 2016-2027 (Million US$)
Figure Prevention Case Studies
Figure Diagnostic Case Studies
Figure Treatment Case Studies
Figure Chronic Obstructive Pulmonary Disease Report Years Considered
Table Global Chronic Obstructive Pulmonary Disease Market Size 2016-2027 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions 2016-2027 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions 2016-2020 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2016-2020
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2016-2020
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2020
Table Market Top Trends
Table Global Chronic Obstructive Pulmonary Disease Revenue by Manufacturers (2020) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Share by Manufacturers (2020)
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Manufacturers in 2020
Table Global Chronic Obstructive Pulmonary Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Obstructive Pulmonary Disease Product/Solution/Service
Table Date of Enter into Chronic Obstructive Pulmonary Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size Share by Type (2016-2020)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2016-2020)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size Share by Application (2016-2020)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2016-2020)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application in 2020
Figure United States Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table United States Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table United States Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table United States Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table United States Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure Europe Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure China Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table China Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table China Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table China Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table China Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure Japan Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table Japan Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table Japan Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure India Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table India Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table India Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table India Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table India Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Figure Central & South America Chronic Obstructive Pulmonary Disease Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disease Revenue (2020) (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disease Market Share (2020)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2020) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2020)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2020) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2020)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2020) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table AstraZeneca Recent Development
Table GSK Company Details
Table GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table GSK Recent Development
Table MSD Company Details
Table MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure MSD Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table MSD Recent Development
Table Sunovion Company Details
Table Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Sunovion Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Sunovion Recent Development
Table Novartis Company Details
Table Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Novartis Recent Development
Table Roche Group Company Details
Table Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Roche Group Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Roche Group Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Pfizer Recent Development
Table Jubilant Pharma Limited Company Details
Table Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Jubilant Pharma Limited Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Jubilant Pharma Limited Recent Development
Table Almirall Company Details
Table Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Almirall Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2020)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2020)
Table Horizon Pharma Recent Development
Table Boehringer Ingelheim Company Details
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions (Million US$) 2021-2027
Figure Global Chronic Obstructive Pulmonary Disease Market Size Share by Regions (2021-2027)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Share by Regions in 2027
Figure United States Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure Europe Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure China Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure Japan Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure India Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Chronic Obstructive Pulmonary Disease Market Size Forecast (2021-2027)(Million USD)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Product (2021-2027) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Product (2021-2027)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Product in 2027
Table Global Chronic Obstructive Pulmonary Disease Market Size by Application (2021-2027) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Application (2021-2027)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources